Clinical Trials
3 trialsNCT00694551 2019-10-04
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT02429440 2017-08-17
UroRCC
University Hospital Tuebingen
Phase 1/2 Unknown
NCT02452307 2017-08-17
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
University Hospital Tuebingen
Phase 1/2 Unknown